NKG2D/CLDN18.21 CAR-T(KD-496) in the Treatment of Advanced NKG2DL+/CLDN18.2+ Solid Tumor
NCT06134960
·
clinicaltrials.gov ↗
PHASE1
Phase
NOT_YET_RECRUITING
Status
12
Enrollment
OTHER
Sponsor class
Conditions
Gastric Cancer
Pancreatic Cancer
Solid Tumor
Interventions
BIOLOGICAL:
KD-496
Sponsor
Peking University
Collaborators
[object Object]